294 related articles for article (PubMed ID: 10439042)
21. Pax3:Fkhr interferes with embryonic Pax3 and Pax7 function: implications for alveolar rhabdomyosarcoma cell of origin.
Keller C; Hansen MS; Coffin CM; Capecchi MR
Genes Dev; 2004 Nov; 18(21):2608-13. PubMed ID: 15520281
[TBL] [Abstract][Full Text] [Related]
22. An engineered PAX3-KRAB transcriptional repressor inhibits the malignant phenotype of alveolar rhabdomyosarcoma cells harboring the endogenous PAX3-FKHR oncogene.
Fredericks WJ; Ayyanathan K; Herlyn M; Friedman JR; Rauscher FJ
Mol Cell Biol; 2000 Jul; 20(14):5019-31. PubMed ID: 10866659
[TBL] [Abstract][Full Text] [Related]
23. Minimal disease detection in patients with alveolar rhabdomyosarcoma using a reverse transcriptase-polymerase chain reaction method.
Kelly KM; Womer RB; Barr FG
Cancer; 1996 Sep; 78(6):1320-7. PubMed ID: 8826957
[TBL] [Abstract][Full Text] [Related]
24. [Detection of PAX3/PAX7-FKHR fusion transcript in rhabdomyosarcoma by one-step RT-PCR].
Chang B; Yin BM; Li F; Li XX; Lu TC; Hu WH; Jiang JF; Shi DR
Zhonghua Yi Xue Za Zhi; 2003 Aug; 83(15):1336-8. PubMed ID: 12930690
[TBL] [Abstract][Full Text] [Related]
25. Induction of apoptosis in rhabdomyosarcoma cells through down-regulation of PAX proteins.
Bernasconi M; Remppis A; Fredericks WJ; Rauscher FJ; Schäfer BW
Proc Natl Acad Sci U S A; 1996 Nov; 93(23):13164-9. PubMed ID: 8917562
[TBL] [Abstract][Full Text] [Related]
26. Analysis of the transforming and growth suppressive activities of the PAX3-FKHR oncoprotein.
Xia SJ; Barr FG
Oncogene; 2004 Sep; 23(41):6864-71. PubMed ID: 15286710
[TBL] [Abstract][Full Text] [Related]
27. A genetic analysis of PAX3-FKHR, the oncogene of alveolar rhabdomyosarcoma.
Kempf BE; Vogt PK
Cell Growth Differ; 1999 Dec; 10(12):813-8. PubMed ID: 10616906
[TBL] [Abstract][Full Text] [Related]
28. The role of Pax3 and Pax7 in development and cancer.
Mansouri A
Crit Rev Oncog; 1998; 9(2):141-9. PubMed ID: 9973247
[TBL] [Abstract][Full Text] [Related]
29. Pax3-fkhr and pax7-fkhr fusion genes impact outcome of alveolar rhabdomyosarcoma in children.
Kazanowska B; Reich A; Stegmaier S; Békássy AN; Leuschner I; Chybicka A; Koscielniak E
Fetal Pediatr Pathol; 2007; 26(1):17-31. PubMed ID: 17613043
[TBL] [Abstract][Full Text] [Related]
30. Identification of a PAX-FKHR gene expression signature that defines molecular classes and determines the prognosis of alveolar rhabdomyosarcomas.
Davicioni E; Finckenstein FG; Shahbazian V; Buckley JD; Triche TJ; Anderson MJ
Cancer Res; 2006 Jul; 66(14):6936-46. PubMed ID: 16849537
[TBL] [Abstract][Full Text] [Related]
31. Hormone-dependent tumor regression in vivo by an inducible transcriptional repressor directed at the PAX3-FKHR oncogene.
Ayyanathan K; Fredericks WJ; Berking C; Herlyn M; Balakrishnan C; Gunther E; Rauscher FJ
Cancer Res; 2000 Oct; 60(20):5803-14. PubMed ID: 11059777
[TBL] [Abstract][Full Text] [Related]
32. The oncogenic potential of the Pax3-FKHR fusion protein requires the Pax3 homeodomain recognition helix but not the Pax3 paired-box DNA binding domain.
Lam PY; Sublett JE; Hollenbach AD; Roussel MF
Mol Cell Biol; 1999 Jan; 19(1):594-601. PubMed ID: 9858583
[TBL] [Abstract][Full Text] [Related]
33. PAX7 expression in embryonal rhabdomyosarcoma suggests an origin in muscle satellite cells.
Tiffin N; Williams RD; Shipley J; Pritchard-Jones K
Br J Cancer; 2003 Jul; 89(2):327-32. PubMed ID: 12865925
[TBL] [Abstract][Full Text] [Related]
34. Correlation between histology and PAX/FKHR fusion status in alveolar rhabdomyosarcoma: a report from the Children's Oncology Group.
Parham DM; Qualman SJ; Teot L; Barr FG; Morotti R; Sorensen PH; Triche TJ; Meyer WH;
Am J Surg Pathol; 2007 Jun; 31(6):895-901. PubMed ID: 17527077
[TBL] [Abstract][Full Text] [Related]
35. Global gene expression profiling of PAX-FKHR fusion-positive alveolar and PAX-FKHR fusion-negative embryonal rhabdomyosarcomas.
Laé M; Ahn EH; Mercado GE; Chuai S; Edgar M; Pawel BR; Olshen A; Barr FG; Ladanyi M
J Pathol; 2007 Jun; 212(2):143-51. PubMed ID: 17471488
[TBL] [Abstract][Full Text] [Related]
36. PAX3-FKHR induces morphological change and enhances cellular proliferation and invasion in rhabdomyosarcoma.
Anderson J; Ramsay A; Gould S; Pritchard-Jones K
Am J Pathol; 2001 Sep; 159(3):1089-96. PubMed ID: 11549601
[TBL] [Abstract][Full Text] [Related]
37. Regulated expression of the diphtheria toxin A chain by a tumor-specific chimeric transcription factor results in selective toxicity for alveolar rhabdomyosarcoma cells.
Massuda ES; Dunphy EJ; Redman RA; Schreiber JJ; Nauta LE; Barr FG; Maxwell IH; Cripe TP
Proc Natl Acad Sci U S A; 1997 Dec; 94(26):14701-6. PubMed ID: 9405676
[TBL] [Abstract][Full Text] [Related]
38. A Drosophila model of the rhabdomyosarcoma initiator PAX7-FKHR.
Galindo RL; Allport JA; Olson EN
Proc Natl Acad Sci U S A; 2006 Sep; 103(36):13439-44. PubMed ID: 16938866
[TBL] [Abstract][Full Text] [Related]
39. Alternate PAX3 and PAX7 C-terminal isoforms in myogenic differentiation and sarcomagenesis.
Charytonowicz E; Matushansky I; Castillo-Martin M; Hricik T; Cordon-Cardo C; Ziman M
Clin Transl Oncol; 2011 Mar; 13(3):194-203. PubMed ID: 21421465
[TBL] [Abstract][Full Text] [Related]
40. Inducible short-term and stable long-term cell culture systems reveal that the PAX3-FKHR fusion oncoprotein regulates CXCR4, PAX3, and PAX7 expression.
Tomescu O; Xia SJ; Strezlecki D; Bennicelli JL; Ginsberg J; Pawel B; Barr FG
Lab Invest; 2004 Aug; 84(8):1060-70. PubMed ID: 15184910
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
